Biotechnology Bulletin ›› 2016, Vol. 32 ›› Issue (9): 246-252.doi: 10.13560/j.cnki.biotech.bull.1985.2016.09.033
Previous Articles Next Articles
CHEN Yun, NIU Chun-qing, SONG Xiao-shuang, SU Chang, HUA Zi-chun, LIU Yan
Received:
2016-01-08
Online:
2016-09-25
Published:
2016-10-10
CHEN Yun1, NIU Chun-qing1, SONG Xiao-shuang1, SU Chang1, HUA Zi-chun2, LIU Yan1. Expression and Activity Analysis of DSPAα1 Deletion Mutants in Pichia pastoris[J]. Biotechnology Bulletin, 2016, 32(9): 246-252.
[1] Gardell SJ, Duong LT, Diehl RE, et al. Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator[J]. Journal of Biological Chemistry, 1989, 264(30):17947-17952. [2] Krätzschmar J, Haendler B, Langer G, et al. The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundas:cloning and expression[J]. Gene, 1991, 105(2):229-237. [3] Bringmann P, Gruber D, Liese A, et al. Structural features mediating fibrin selectivity of vampire bat plasminogen activators[J]. Journal of Biological Chemistry, 1995, 270(43):25596-25603. [4] Gardell SJ, Hare TR, Bergum PW, et al. Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activator[J]. Blood, 1990, 76(12):2560-2564. [5] Bergum PW, Gardell SJ. Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis[J]. Journal of Biological Chemistry, 1992, 267(25):17726-17731. [6] Witt W, Maass B, Baldus B, et al. Coronary thrombolysis with Desmodus salivary plasminogen activator in dogs. Fast and persistent recanalization by intravenous bolus administration[J]. Circulation, 1994, 90(1):421-426. [7] Stewart RJ, Fredenburgh JC, Weitz JI. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E[J]. Journal of Biological Chemistry, 1998, 273(29):18292-18299. [8] Montoney M, Gardell SJ, Marder VJ. Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model[J]. Circulation, 1995, 91(5):1540-1544. [9] Gardell SJ, Ramjit DR, Stabilito II, et al. Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits[J]. Circulation, 1991, 84(1):244-253. [10] Schleuning WD. Vampire bat plasminogen activator DSPA-alpha-1(desmoteplase):a thrombolytic drug optimized by natural selection[J]. Pathophysiology of Haemostasis and Thrombosis, 2001, 31(3-6):118-122. [11] 董宁征, 吴庆宇, 潘峻亮, 等. dsPAα1 的缺失突变体的构建及其活性[J]. 中国生物化学与分子生物学报, 2004, 20:805-809. [12] 刘堰, 苏畅, 宋小双, 等. 表达食血蝙蝠唾液纤溶酶原激活剂的毕赤酵母菌株的构建[J]. 生物工程学报, 2009, 25(4):566-574. [13] Marsh NA, Gaffney PJ. The rapid fibrin plate-a method for plasminogen activator assay[J]. Thrombosis and Haemostasis, 1977, 38(2):545-551. [14] Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial(DIAS)a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase[J]. Stroke, 2005, 36(1):66-73. [15] Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT(DIAS-2):a prospective, randomised, double-blind, placebo-controlled study[J]. The Lancet Neurology, 2009, 8(2):141-150. [16] Kummer R, Albers GW, Mori E. The desmoteplase in acute ischemic stroke(DIAS)clinical trial program[J]. International Journal of Stroke, 2012, 7(7):589-596. [17] Balami JS, Chen R, Sutherland BA, et al. Thrombolytic agents for acute ischaemic stroke treatment:the past, present and future[J]. CNS & Neurological Disorders-Drug Targets, 2013, 12(2):145-154. [18] Patel R, Ispoglou S, Apostolakis S. Desmoteplase as a potential treatment for cerebral ischaemia[J]. Expert Opinion on Investigational Drugs, 2014, 23(6):865-873. [19] Albers GW, von Kummer R, Truelsen T, et al. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries(DIAS-3):a double-blind, randomised, placebo-controlled phase 3 trial[J]. The Lancet Neurology, 2015, 14(6):575-584. [20] Krätzschmar J, Haendler B, Bringmann P, et al. High-level secretion of the four salivary plasminogen activators from the vampire bat Desmodus rotundus by stably transfected baby hamster kidney cells[J]. Gene, 1992, 116(2):281-284. [21] Petri T, Langer G, Bringmann P, et al. Production of vampire bat plasminogen activator DSPA α1 in CHO and insect cells[J]. Journal of Biotechnology, 1995, 39(1):75-83. [22] Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris[J]. FEMS Microbiology Reviews, 2000, 24(1):45-66. [23] 李剑凤, 阎岩, 王庆民, 等. N-糖基化对毕赤酵母表达的 DSPAα1 分泌和活性的影响[J]. 生物工程学报, 2010, 26(9):1287-1292. [24] 张丞斌, 傅正伟. 影响外源蛋白在巴斯德毕赤酵母中表达和分泌的研究进展[J]. 现代生物医学进展, 2008, 8(7):1382-1384. [25] Clare JJ, Rayment FB, Ballantine SP, et al. High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene[J]. Bio/Technolgy, 1991, 9(5):455-460. [26] Peng YC, Acheson NH. Production of active polyomavirus large T antigen in yeast Pichia pastoris[J]. Virus research, 1997, 49(1):41-47. [27] Clare J, Scorer C, Buckholz R, et al. Expression of EGF and HIV envelope glycoprotein[M]// Higgins DR, Cregg JM. Pichia protocols. Totowa:Humana Press, 1998:209-225. |
[1] | ZHAO Si-jia, WANG Xiao-lu, SUN Ji-lu, TIAN Jian, ZHANG Jie. Modification of Pichia pastoris for Erythritol Production by Metabolic Engineering [J]. Biotechnology Bulletin, 2023, 39(8): 137-147. |
[2] | DONG Cong, GAO Qing-hua, WANG Yue, LUO Tong-yang, WANG Qing-qing. Increasing the Expression of FAD-dependent Glucose Dehydrogenase by Recombinant Pichia pastoris Using a Combined Strategy [J]. Biotechnology Bulletin, 2023, 39(6): 316-324. |
[3] | WANG Yue, GAO Qing-hua, DONG Cong, LUO Tong-yang, WANG Qing-qing. Expression of Pyranose Oxidase with Optimized Codon in Pichia pastoris [J]. Biotechnology Bulletin, 2022, 38(4): 269-277. |
[4] | YANG Wei, WU Xi, CHENG Jian-guo, LUO Yan, WANG Yin, YANG Ze-xiao, YAO Xue-ping. Cloning,Expression and Transcriptional Regulation of Interferon-α in Forest Musk Deer [J]. Biotechnology Bulletin, 2022, 38(1): 194-204. |
[5] | LIAO Zhao-min, CAI Jun, LIN Jian-guo, DU Xin, WANG Chang-gao. Expression of Glucose Oxidase Gene from Aspergillus niger in Pichia pastoris and Optimization of Enzyme Production Conditions [J]. Biotechnology Bulletin, 2021, 37(6): 97-107. |
[6] | YANG Yue, TAO Yan, XIE Jing, QIAN Yun-fang. Biosynthesis of Ctenopharyngodon idella C-type Lysozyme Based on Recombinant Pichia pastoris and Its Antibacterial Activity [J]. Biotechnology Bulletin, 2021, 37(12): 169-179. |
[7] | ZHAO Zhen, WANG Sha-sha, LÜ Xing-xing, TAO Yan, XIE Jing, QIAN Yun-fang. Heterologous Expression of Cyclina sinensis Mytimacin Antibacterial Peptide Based on Recombinant Pichia pastoris [J]. Biotechnology Bulletin, 2020, 36(5): 150-158. |
[8] | MIN Qi, GAO Zi-han, YAO Yin, ZHANG Hua-shan, XIONG Hai-rong, ZHANG Li. Effect of Co-expression of HAC1 and Molecular Chaperone Genes on the Expression of Mannanase in Pichia pastoris [J]. Biotechnology Bulletin, 2020, 36(5): 159-168. |
[9] | LI Ya-nan, YU Li-hong, CHEN Xin-mei, YANG Hao-meng, HUANG Huo-qing. Expression and Characterization of Aquatic Neutral Phytase Gene from Penicillium sp. C1 in Pichia pastoris [J]. Biotechnology Bulletin, 2020, 36(2): 134-141. |
[10] | ZHANG Ya-li, TAO Yan, XIE Jing, QIAN Yun-fang. Recombinant Expression of Mytilus coruscus Mytilin-1 Mature Peptide in Pichia pastoris and Its Antibacterial Activity [J]. Biotechnology Bulletin, 2019, 35(7): 54-60. |
[11] | HOU Cheng-lin, YANG Yan-kun, CHEN Jia-li, BAI Zhong-hu. Preliminary Study on the Regulation of Mxr1 Phosphorylation by Ptp [J]. Biotechnology Bulletin, 2019, 35(7): 108-113. |
[12] | DONG Cong, GAO Qing-hua, WANG Yue, LUO Tong-yang. Expression and Enzymatic Characterization of Codon-optimized FAD-dependent Glucose Dehydrogenase in Pichia pastoris [J]. Biotechnology Bulletin, 2019, 35(7): 114-120. |
[13] | LIU Jin-lan, YANG Xue, LI Shuang-shuang, ZHANG Yu-ming, LIU Feng-song, TANG Ting, LI Hong-quan. Eukaryotic Expression of Antibacterial Peptide Domesticin from Musca domestica in Pichia Pastoris and Antibacterial Activity Identification [J]. Biotechnology Bulletin, 2019, 35(2): 109-115. |
[14] | LIU Si-yang, WANG Yan, FU Yu-qin, HU Xiang-kun, WANG Ming-yu, LU Tian-cheng, WANG Xiu-ran. Effect of Glycosylation of Brucella P39 Antigen in Pichia pastoris on Macrophage Phagocytosis [J]. Biotechnology Bulletin, 2018, 34(9): 237-243. |
[15] | GAO Qing-hua, DONG Cong, WANG Yue, HU Mei-rong, WANG Qing-qing, WANG Yun-peng, LUO Tong-yang, LIU Lei. Enhancement of Glucose Oxidase in Pichia pastoris by Co-expressing Chaperone PDI and Ero1 [J]. Biotechnology Bulletin, 2018, 34(7): 174-179. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 247
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 224
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||